CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies

Chimeric antigen receptor (CAR)-T cell therapy is undeniably a promising tool in combating various types of hematological malignancies. However, it is not yet optimal and a significant number of patients experience a lack of response or relapse after the treatment. Therapy improvement requires caref...

Descripción completa

Detalles Bibliográficos
Autores principales: Marhelava, Katsiaryna, Krawczyk, Marta, Firczuk, Malgorzata, Fidyt, Klaudyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180412/
https://www.ncbi.nlm.nih.gov/pubmed/35681499
http://dx.doi.org/10.3390/cells11111804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180412/
https://www.ncbi.nlm.nih.gov/pubmed/35681499
http://dx.doi.org/10.3390/cells11111804

Ejemplares similares